Nuvalent (NUVL) Retained Earnings (2020 - 2026)
Nuvalent (NUVL) reported Retained Earnings of -$1.1 billion for Q1 2026, down 128905.62% on a YoY basis from N/an in Q1 2025, and down 13.12% quarter-over-quarter from -$972.4 million in Q4 2025.
Nuvalent (NUVL) Retained Earnings (2020 - 2026) Analysis & Trends
Nuvalent has reported Retained Earnings for 7 years, with the latest figure at -$1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 128905.62% year-over-year to -$1.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.1 billion (down 128905.62% YoY), and the FY2025 full-year result was -$972.4 million, down 1648084.75% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.1 billion, down from -$972.4 million in the prior quarter.
- The five-year high for Retained Earnings was $854000.0 in Q1 2025, with the low at -$1.1 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$288.9 million across 5 years, with a median of -$114.2 million in 2022.
- The largest YoY upside for Retained Earnings was 164.8% in 2025 against a maximum downside of 1648084.75% in 2025.
- Nuvalent's Retained Earnings stood at -$494000.0 in 2022, then surged by 106.28% to $31000.0 in 2023, then tumbled by 290.32% to -$59000.0 in 2024, then sank by 1648084.75% to -$972.4 million in 2025, then dropped by 13.12% to -$1.1 billion in 2026.
- The last three Retained Earnings figures came in at -$1.1 billion (Q1 2026), -$972.4 million (Q4 2025), and -$853.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | -1.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.10 Bn |
| Dec 31, 2025 | -972.43 Mn |
| Sep 30, 2025 | -853.70 Mn |
| Jun 30, 2025 | -731.30 Mn |
| Mar 31, 2025 | 854,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -472.30 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | -248.00 Mn |
| Jun 30, 2023 | -1.54 Mn |
| Mar 31, 2023 | -185.27 Mn |
| Dec 31, 2022 | -494,000.00 |
| Sep 30, 2022 | -134.00 Mn |
| Jun 30, 2022 | -114.24 Mn |
| Mar 31, 2022 | -95.80 Mn |
| Dec 31, 2021 | -78.22 Mn |
| Sep 30, 2021 | -60.93 Mn |
| Jun 30, 2021 | -48.51 Mn |